Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Lonza has introduced an enhanced product line aimed at tackling concerns around bias during blinded clinical trials.
read more
Panthera Biopartners has appointed Chris Dodd as Executive VP of Business Development – Oncology and CNS.
read more
ImmunoPrecise and LiteVax announced a preclinical study to analyze IPA's novel SARS-CoV-2 vaccine candidates, has been granted funding by TRANSVAC2.
read more
Pharm-Olam, a global midsized clinical research organization, has completed a change of ownership transaction on Friday June 19, 2020.
read more
CluePoints announced the launch of its new business intelligence platform, BEYOND.
read more
Headlands Research announced its acquisition of two large CNS-focused clinical research centers; JEM Research Institute and Toronto Memory Program.
read more
SGS has received approval from FAMHP and has initiated the first site to begin a new clinical trial of a potential treatment for patients with COVID-19 related respiratory failure.
read more
LGC has announced the acquisition of The Native Antigen Company (NAC), a supplier of infectious disease antigens and antibodies.
read more
Headlands Research announced its research centers have been selected to participate in numerous upcoming COVID-19 vaccine clinical trials.
read more
ERT announced a preferred partnership with neuroscience technology company, Cogstate.
read more
Strata has signed an agreement with BioMed to accelerate patient identification and enrollment for BioMed Valley's Phase 2 study of BVD-523 for advanced malignancies harboring MEK or atypical BRAF alterations.
read more
Wednesday, August 05, 2020
The AAHRPP has awarded the Advarra institutional review board full reaccreditation.
read more
Wednesday, August 19, 2020
BEKHealth and Devana Solutions have finalized an agreement to integrate their platforms.
read more
Wednesday, August 26, 2020
SubjectWell is working with pharmaceuticals to recruit patients for Phase 2 and Phase 3 COVID-19 vaccine trials.
read more
Thursday, August 27, 2020
Since launching its first site in Preston in North West England in 2019, Panthera has expanded its network of UK clinical trial sites with a new site in North London.
read more